Align Technology, Inc. (Nasdaq: ALGN) said it will appoint three new independent directors to its board, hire a consulting firm to review its operating model, and increase its 2026 share repurchase commitment, following discussions with activist investor Elliott Investment Management.

The board additions will focus on candidates with experience in healthcare technology, medical devices, global operations, and consumer technology. No specific names were announced.

The company has engaged an unidentified consulting firm to conduct a strategic and operating model review covering commercial execution, organizational effectiveness, and resource allocation. Align said it intends to update shareholders on material initiatives and progress from the review.

Align raised its 2026 share repurchase target to a range of $400 million to $500 million of common stock, up from a previously stated commitment.

"The initiatives build on efforts already underway to strengthen our business, evolve our operating model, and ensure our Board continues to reflect the capabilities needed to support Align's future growth opportunities," said Joe Hogan, Align's president and CEO.

Elliott partner Marc Steinberg said the firm is one of Align's largest investors and called the announcements "important steps." The firm did not disclose the size of its stake.

Kevin Conroy, chairman of Align's board, said the three new directors will be appointed as part of the board's ongoing refreshment process and credited Elliott with constructive dialogue in the process.